Back

Watch Compare

PLIANT THERAPEUTICS, INC.

Data quality: 100%

PLRX

Nasdaq Manufacturing Chemicals

$1.36

▼ $0.01 (-0.37%)

Mkt Cap: 83.89 M

Price

$1.36

Mkt Cap

83.89 M

Day Range

$1.32 — $1.37

52-Week Range

$1.09 — $1.95

Volume

188,908

Open $1.36

50D / 200D Avg

$1.26

7.81% above

50D / 200D Avg

$1.42

4.91% below

Quick Summary

Key Takeaways

Debt/Equity of 0.15 — conservative balance sheet

Negative free cash flow of -128.71 M

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

-71.05%

Below sector avg (-53.41%)

ROIC-45.91%

Net MarginN/A

Op. MarginN/A

Safety

Debt / Equity

0.15

Below sector avg (0.31)

Current Ratio13.93

Interest Coverage-61.11

Valuation

PE (TTM)

-0.56

Above sector avg (-1.48)

P/B Ratio0.42

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	-0.6	-1.5
P/B	0.4	1.6
ROE %	-71.1	-53.4
Net Margin %	—	-41.5
Rev Growth 5Y %	—	1.8
D/E	0.2	0.3

ETFs Holding This Stock

BRUSX BRUSX

0.32% weight

QWVOX QWVOX

0.01% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	0.0	Net Income (TTM)	-149.34 M
ROE	-71.05%	ROA	-51.82%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-128.71 M
ROIC	-45.91%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0.15	Current Ratio	13.93
Interest Coverage	-61.11	Asset Turnover	0.00
Working Capital	227.96 M	Tangible Book Value	200.31 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-0.56	Forward P/E	N/A
P/B Ratio	0.42	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-153.42%
Market Cap	83.89 M	Enterprise Value	20.60 M
Per Share
EPS (Diluted TTM)	-2.43	Revenue / Share	0.00
FCF / Share	-2.08	OCF / Share	-2.07
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	86.18%
SBC-Adj. FCF	-159.32 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	0.0	0.0	1.58 M	9.69 M	7.57 M
Net Income	-149.34 M	-210.30 M	-161.34 M	-123.32 M	-97.26 M
EPS (Diluted)	-2.43	-3.47	-2.75	-2.94	-2.71
Gross Profit	—	—	—	—	—
Operating Income	-156.37 M	-228.37 M	-184.15 M	-127.20 M	-97.54 M
EBITDA	—	—	—	—	—
R&D Expenses	109.16 M	169.31 M	127.80 M	96.94 M	77.55 M
SG&A Expenses	—	—	—	—	—
D&A	—	—	—	—	—
Interest Expense	2.56 M	3.02 M	1.27 M	0.0	—
Income Tax	0.0	0.0	0.0	0.0	—

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	225.23 M	396.95 M	512.15 M	350.61 M	221.22 M
Total Liabilities	44.02 M	92.87 M	38.58 M	37.27 M	22.16 M
Shareholders' Equity	181.21 M	304.08 M	473.58 M	313.34 M	199.06 M
Total Debt	0.0	30.21 M	10.05 M	9.93 M	—
Cash & Equivalents	45.45 M	71.19 M	63.23 M	33.69 M	51.67 M
Current Assets	196.45 M	362.26 M	505.50 M	340.31 M	209.44 M
Current Liabilities	16.37 M	33.22 M	28.52 M	23.91 M	16.83 M